What question did this study set out to answer?

To establish updated, evidence-based recommendations for the diagnosis, cardiovascular risk assessment, and management of dyslipidemia.

January 1, 2019Journal of Lipid and AtherosclerosisOpen Access

2018 Guidelines for the Management of Dyslipidemia in Korea

View Full Paper

Ask AI

Bookmark

To establish updated, evidence-based recommendations for the diagnosis, cardiovascular risk assessment, and management of dyslipidemia.
Synthesized findings from local Korean epidemiological datasets, randomized clinical trials, and international clinical guidelines.
Stratified cardiovascular risk into very high-, high-, moderate-, and low-risk categories to establish target lipid thresholds.
Formulated treatment algorithms combining therapeutic lifestyle modifications with pharmacological agents, including statins, ezetimibe, and PCSK9 inhibitors.
Established low-density lipoprotein cholesterol (LDL-C) target thresholds of <70 mg/dL for very high-risk individuals, <100 mg/dL for high-risk individuals, <130 mg/dL for moderate-risk individuals, and <160 mg/dL for low-risk individuals.
Designated statin monotherapy as the primary first-line pharmacological treatment, recommending combination therapy with ezetimibe or PCSK9 inhibitors when target LDL-C levels remain unachieved.
Advised lifestyle interventions focusing on energy-balanced diets, regular aerobic exercise, weight reduction, and smoking cessation across all risk groups.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Clinical practice guideline presents risk-stratified lipid targets and treatment algorithms for Korean adults, highlighting individualized statin-based therapy for cardiovascular prevention.

Abstract

[Image: see text]

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rhee et al. (2019) studied this question.

synapsesocial.com/papers/69da9691387cf70698686fe8 https://doi.org/10.12997/jla.2019.8.2.78

View Full Paper

Ask AI

Bookmark

Implication

Clinical practice guideline presents risk-stratified lipid targets and treatment algorithms for Korean adults, highlighting individualized statin-based therapy for cardiovascular prevention.

Abstract

[Image: see text]

2018 Guidelines for the Management of Dyslipidemia in Korea

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

2018 Guidelines for the Management of Dyslipidemia in Korea

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading